Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 April 2022 | Story Bhekumusa N. Zikhali
Africa Week
2022 Africa Week: ‘African Higher Education – Celebrating African Education’



Celebrating Africa Month – call for contributions


The University of the Free State Office for International Affairs, in collaboration with the Unit for Institutional Change and Social Justice, will be hosting its fifth annual Africa Day commemoration. The 2022 commemoration will be hosted across all three campuses in a marathon we call Africa Week, which unifies the activities through cross-campus collaboration speaking in one voice for one institution. The activities will be three-tiered, starting with an opening ceremony for Africa Week on the South Campus, a celebratory dialogue on the Bloemfontein Campus, and lastly, the closing ceremony of Africa Week on the Qwaqwa Campus. All three activities will be embodied under the theme ‘African Higher Education – Celebrating African Education’, which will embrace artistic expressions, music, dance, and meaningful dialogue that will provide an element for teaching and learning. You are all cordially invited to tune in.

In accordance with COVID-19 protocols/rules, the different activities will have limited capacity for attendance, but live streaming will be made available to the rest of us. This may change at any given time according to circumstances as determined by the relevant departments of the institution.

You are all cordially invited to tune in; be on the lookout for the RSVP link for attendance. In the meantime, save the date and the links below.

Livestream link: https://livestream.ufs.ac.za/

Opening Ceremony South Campus
Date: 23 May 2022
Venue: Open space outside the cafeteria
Time: 13:00 – 15:00

Celebratory Dialogue Bloemfontein Campus
Date: 25 May 2022
Venue: Centenary Complex
Time: 16:00 – 19:00

Closing Ceremony Qwaqwa Campus
Date: 27 May 2022
Venue: VIP Hall
Time: 12:30 – 15:00





 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept